Burgan, Kaylee
McCollum, C. Greer
Guzman, Alfredo
Penney, Brooke
Hill, Samantha V.
Kudroff, Kachina
Thorn, Shey
Burton, Toya
Turner, Kelly
Mugavero, Michael J.
Rana, Aadia
Elopre, Latesha
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (P30 AI027767)
Article History
Received: 19 April 2023
Accepted: 7 December 2023
First Online: 18 January 2024
Declarations
:
: This study’s protocols, documents, and forms were approved by the University of Alabama at Birmingham (UAB) Institutional Review Board (IRB). The approved IRB protocol number for the present study is IRB-300004157. Due to the ongoing COVID-19 pandemic, all interviews were conducted virtually; therefore, the study team received IRB approval to waive documentation of informed consent. Written informed consent was deemed unsafe due to the COVID-19 pandemic. Participants were given an information sheet during recruitment to review and ask questions prior to sharing the survey or scheduling the interview. During the interview, informed consent was obtained verbally and recorded as part of the transcript.
: Not applicable.
: The authors declare no competing interests.